Frazier Life Sciences Management, L.P. - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 99 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.

Quarter-by-quarter ownership
Frazier Life Sciences Management, L.P. ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$204,464,387
+81.3%
6,470,392
+48.4%
13.58%
+101.6%
Q2 2023$112,795,968
+21.7%
4,360,107
+13.0%
6.74%
+0.3%
Q1 2023$92,719,770
+23.2%
3,860,1070.0%6.71%
+43.4%
Q4 2022$75,272,087
-6.4%
3,860,107
+0.8%
4.68%
-24.4%
Q3 2022$80,422,000
+15.9%
3,827,781
+7.3%
6.19%
-5.5%
Q2 2022$69,412,000
-11.6%
3,566,9120.0%6.55%
-2.1%
Q1 2022$78,543,0003,566,9126.69%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,566,912$62,278,0004.80%
RiverVest Venture Management LLC 1,921,118$33,543,0003.68%
Burrage Capital Management LLC 161,628$2,822,0002.15%
AIGH Capital Management LLC 274,583$4,794,0001.95%
NEA Management Company, LLC 4,187,801$73,119,0001.93%
Novo Holdings A/S 2,445,147$42,692,0001.83%
Sio Capital Management, LLC 494,743$8,638,0001.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,448,912$60,218,0001.19%
Rock Springs Capital Management LP 1,496,525$26,129,0000.55%
Prosight Management, LP 60,250$1,052,0000.49%
View complete list of MIRUM PHARMACEUTICALS INC shareholders